The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients
Clinical trial NCT04475107 · COMPLETED
Trial details
- NCT number
- NCT04475107
- Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-09
- Primary completion
- 2021-03-25
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.